Introduction
Habitual snoring, a reliable indicator of increased upper airway resistance during sleep, is a frequent symptom during childhood, being reported in 10% of 2-8-year-old children [1] [2] [3] [4] [5] [6] [7] [8] , with decreases in this frequency after 9-10 years of age [9] . The polysomnographic criteria that allow for differentiation between innocent snoring (i.e., habitual snoring that does not lead to gas exchange abnormalities, sleep disruption, and/or to any morbid consequences) and snoring that leads to adverse consequences have yet to be defined (see pp. 000-000). Nevertheless, based on a consensus statement published in 2002 [10] , it is estimated that the ratio between symptomatic habitual snoring and obstructive sleep apnea (OSA) revolves around 3 : 1-5 : 1 [11] .
The prevalence and severity of overweight and obesity in children and adolescents have markedly increased worldwide in the last decades [12, 13] . In the United States, the prevalence of childhood overweight doubled among children 6-11 years of age and tripled among 12-17-year-old children between 1980 and 2000 [14, 15] . The presence of overweight or obesity has been repeatedly associated with an increased risk for OSA [16] [17] [18] [19] [20] [21] [22] . Indeed, whereas in the early years following description of the initial cases of pediatric OSA only 10% or even fewer of those who were diagnosed with OSA were obese, Mallory et al. [18] later showed the presence of polysomnographic abnormalities in 24% of 41 obese children. Similarly, Silvestri et al. [19] found evidence for partial airway obstruction in 66% and complete airway obstruction in 59% of the 32 obese children. In a case-control study design, Redline et al. [16] examined risk factors for sleepdisordered breathing in children aged 2-18 years and found that the risk among obese children was increased by 4-5-fold. In fact, for every increment in BMI of 1 kg/m 2 beyond the mean BMI for age and sex, the risk of OSA increased by 12% [16] . Similar trends demonstrating an increased risk of OSA among obese and overweight children have been reported from all over the world. In this context, we have recently reported that the presence of obesity appears to modify the end-organ susceptibility to OSA and alters important aspects of the clinical syndrome, such that two distinct conditions can readily be identified [23 ,24] . Notwithstanding the importance of such considerations, a detailed review of the differences between obese and nonobese children with OSA is beyond the scope of this article. Here, we will, therefore, examine some of the more salient aspects of end-organ morbidity associated with OSA in children and also critically assess the efficacy of current standard treatment approaches for this disease.
Morbidity of obstructive sleep apnea in children
As in adults afflicted with the disease, OSA in children is associated with an extensive array of morbidities, primarily affecting neurobehavioral and cardiovascular systems [25 ,26 ,27 ] . However, although a dose-dependent relationship between the severity of OSA and the magnitude of end-organ dysfunction has emerged, there is significant variability in the presence of clinically meaningful deficits [28] [29] [30] [31] . Furthermore, despite the traditional view that habitual snoring is essentially a benign condition, we have recently shown that such children display a higher risk for neurobehavioral deficits, albeit less severe than the deficits found in children with OSA [30, 31] . For example, higher snore-induced arousal indices in young infants will be associated with reduced scores on standardized mental developmental assessments, thereby consolidating the concept that snoring is not just an innocent noise during sleep, and that, in fact, habitual snoring may represent the mildest component of the disease spectrum [32] . Thus, at any given level of OSA severity, there will be children with a spectrum of cognitive or cardiovascular function ranging from normal range to severe alterations even in the low range of severity of sleep-disordered breathing. The obvious question for such variable findings is 'why?' and this will be addressed after some of the proposed mechanisms mediating OSA-induced morbidity are reviewed.
Potential mechanisms of end-organ injury in pediatric obstructive sleep apnea
Obviously, the consequences of OSA can be ascribed to the interactions between the nocturnal episodic hypoxemia, hypercapnia, and sleep fragmentation that characterize the disease. It is important to emphasize here that delayed treatment or no treatment of OSA may result in irreversible morbidity [33] .
On the basis of rodent models of OSA, we and others have identified oxidative stress and inflammatory processes as major mediators of increased neuronal cell loss in brain regions underlying learning, behavior, executive function, and memory [34] [35] [36] [37] [38] [39] [40] [41] [42] . Furthermore, the intrinsic activity of proteins such as apolipoprotein E and the ability to promote the activation of signaling cascades underlying cell survival or those mediating neuronal cell repair or neuronal progenitors appear to modify the susceptibility to OSA [43] [44] [45] [46] . Similar mechanisms have thus far been identified in regard to the cardiovascular complications that may arise from OSA [47] [48] [49] [50] 51 ,52
,53].
The findings derived from animal models raise the possibility that the variance in OSA-associated central nervous system (CNS) or cardiovascular susceptibility may be explained, at least in part, by specific gene polymorphisms. Indeed, the presence of apolipoprotein E epsilon 4 allele was associated with an increased probability of abnormalities in cognitive function in children with OSA [54 ] . Similarly, children who developed more prominent inflammatory responses [i.e., increased morning plasma C reactive protein (CRP) levels] were more likely to display altered neurobehavioral results when compared with children with a similar degree of respiratory disturbance but with normal CRP levels [55 ] . Conversely, the higher the serum insulin growth factor 1 responses to OSA, the less likely was the presence of cognitive dysfunction [56] . As a corollary to such findings, particular gene polymorphisms are being identified to explain the variance in hypertension among patients with OSA [57] .
As is the case for many diseases, extrinsic factors such as environment and lifestyle may markedly alter the susceptibility to end-organ injury. For example, overall intellectually enriched daily activities may be protective [58] , and food and micronutrient intake and physical activity patterns may also play a role [59, 60] . Thus, in addition to OSA disease severity, the extent of end-organ morbidity may be accounted for by genetic variance in defense and injury-related pathways, as well as by lifestyle and environmental conditions.
Obstructive sleep apnea as a childhood antecedent of adult disease
An important aspect that has recently emerged regarding OSA in children is the possibility that this disease may interact with other disorders to accelerate or modify their temporal and severity trajectories. This is not a novel concept [61 ] and, indeed, fetal and early childhood environments have been recognized as important determinants of the prevalence and clinical severity of several frequent diseases such as hypertension, diabetes, and ischemic heart disease [62] [63] [64] [65] . We have recently found in a rodent model that exposure to intermittent hypoxia during sleep that mimics the deoxygenation-reoxygenation patterns of OSA in developing rats leads to marked and lifelong alterations in some of the primary mechanisms underlying regulation of blood pressure [66, 67] , and that, when such alterations occur in rats genetically predisposed to develop hypertension, the severity of blood pressure elevations is markedly augmented [68 ] . Interestingly, endothelial dysfunction is present in nonobese children with OSA and is not reversed by treatment of OSA in a subset of children who presented with strong family history of premature cardiovascular disease [69 ] . Taken together, we propose that OSA-induced mechanisms of morbidity may launch the activation of existing disease-related genes in a subset of genetically predisposed children, and, therefore, initiate and propagate the disease processes that mediate such adult-onset disorders, thus leading to their clinical manifestations and enhanced severity at much earlier stages of the lifespan.
Treatment of obstructive sleep apnea in children
OSA in children is most commonly associated with adenotonsillar hypertrophy, even when obesity is present, such that the currently recommended initial treatment consists of surgical removal of the adenoids and tonsils (T&A). In recent years, however, it has become apparent that the putatively favorable outcomes of T&A [70] may not be as favorable after all [71] [72] [73] 74 ,75 ], particularly when OSA is severe preoperatively or when obesity is present. Indeed, the frequency of residual mild OSA after T&A is estimated at 45-50% with an additional 20-25% displaying moderate-to-severe OSA after surgery.
These findings have prompted a heated debate as to whether overnight sleep studies should routinely be conducted after T&A [76 ,77 ] . Additional unresolved issues include the choice of the surgical technique (e.g., cold surgery, coblation, and harmonic laser), the need for tonsillectomy and adenoidectomy vs. nonsurgical approaches [78, 79] , the use of one of these two surgical procedures alone, or whether tonsillotomy is preferable to tonsillectomy [80] [81] [82] .
When residual OSA after T&A is moderate-to-severe, administration of nasal continuous positive airway pressure (CPAP) is usually preferred [83 ] . However, the cost-benefit ratio of CPAP in milder cases of residual OSA probably does not justify its use, such that other approaches are being advocated. For example, antiinflammatory therapy is increasingly being recognized as an alternative to surgery or as an effective intervention in residual mild OSA after T&A [83 ,84-89] . For the sake of completeness, we should also mention that favorable experience with oral appliances and orthodontic approaches for treatment of OSA in children has been recently reported, even if the specific patient selection criteria for such interventions are yet to be delineated [90,91 ,92 ] .
Conclusion
OSA in children is associated with substantial morbidities particularly affecting the central nervous and cardiovascular systems. The occurrence and magnitude of such end-organ dysfunction appear to be regulated not only by the severity of the underlying OSA, but also by specific gene variants and environmental and lifestyle patterns. Furthermore, it is possible that OSA in childhood may trigger the earlier onset and progression of diseases that usually become symptomatic during late adulthood. The conventional wisdom that T&A is all that is needed to effectively treat pediatric OSA needs to be urgently revisited, and the role of nonsurgical alternatives such as CPAP, anti-inflammatory agents, and oral appliances will need to be better defined through appropriate multicenter randomized trials.
